Transcom’s Group CEO, Ms. Simeen Rahman, has three key objectives: achieve exponential growth in its existing industries, expand Transcom further globally through Eskayef Pharmaceuticals, and focus on technology as the next big growth area.
Exponential Growth in Bangladesh
Global Expansion Through Eskayef Pharmaceuticals
Venture into Technology Focused Industries
Expansion in existing industries as Bangladesh has much to offer. The country’s large, growing, and increasingly aspirational consumer base has created immense untapped opportunities in existing and emerging industries.
Transcom’s Eskayef Pharmaceuticals division holds particularly high potential for future growth with a strategy centered around injectables and other complex molecules for the global market. Top international scientists and professionals, who are a part of Eskayef’s team, are already working towards this target.
Transcom’s Eskayef Pharmaceuticals division holds particularly high potential for future growth with a strategy centered around injectables and other complex molecules for the global market. Top international scientists and professionals, who are a part of Eskayef’s team, are already working towards this target.
Emerging industries hold a considerably high potential for future expansion. Transcom is currently interested in new partnerships and joint ventures in the high-tech sphere, particularly in manufacturing core components such as semiconductors. As always, Transcom’s core values will provide the guiding light for the next growth phase.